A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

Clinical trial NCT05292196 · TERMINATED

Trial details

NCT number: NCT05292196
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2022-05-20
Primary completion: 2023-01-11
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.